QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
NASDAQ:JAGX

Jaguar Health Stock Forecast, Price & News

$1.31
-0.01 (-0.76%)
(As of 11/30/2021 04:00 PM ET)
Add
Compare
Today's Range
$1.23
$1.35
50-Day Range
$1.31
$2.48
52-Week Range
$0.64
$13.41
Volume
1.16 million shs
Average Volume
5.12 million shs
Market Capitalization
$63.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.53
30 days | 90 days | 365 days | Advanced Chart
Receive JAGX News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.


Jaguar Health logo

About Jaguar Health

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The firm focuses on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Headlines

Jaguar Health, Inc. (NASDAQ:JAGX) Short Interest Up 68.2% in October
November 18, 2021 |  americanbankingnews.com
Jaguar Health Reports 2021 Third Quarter Financial Results
November 17, 2021 |  finance.yahoo.com
Earnings Preview: Jaguar Health
November 13, 2021 |  benzinga.com
Jaguar Health (JAGX) Set to Announce Earnings on Monday
November 12, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:JAGX
Fax
N/A
Employees
34
Year Founded
N/A

Sales & Book Value

Annual Sales
$9.39 million
Book Value
$0.44 per share

Profitability

Net Income
$-33.81 million
Net Margins
-973.74%
Pretax Margin
-973.74%

Debt

Price-To-Earnings

Miscellaneous

Free Float
47,122,000
Market Cap
$63.16 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/17/2021
Today
11/30/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
3/30/2022

MarketRank

Overall MarketRank

1.87 out of 5 stars

Medical Sector

743rd out of 1,390 stocks

Pharmaceutical Preparations Industry

352nd out of 669 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -












Jaguar Health (NASDAQ:JAGX) Frequently Asked Questions

Is Jaguar Health a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Jaguar Health in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Jaguar Health stock.
View analyst ratings for Jaguar Health
or view top-rated stocks.

How has Jaguar Health's stock been impacted by Coronavirus?

Jaguar Health's stock was trading at $1.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, JAGX shares have decreased by 3.0% and is now trading at $1.31.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Jaguar Health?

Jaguar Health saw a increase in short interest during the month of October. As of October 29th, there was short interest totaling 3,010,000 shares, an increase of 68.2% from the October 14th total of 1,790,000 shares. Based on an average daily volume of 1,890,000 shares, the short-interest ratio is currently 1.6 days. Approximately 7.4% of the shares of the company are sold short.
View Jaguar Health's Short Interest
.

When is Jaguar Health's next earnings date?

Jaguar Health is scheduled to release its next quarterly earnings announcement on Wednesday, March 30th 2022.
View our earnings forecast for Jaguar Health
.

How were Jaguar Health's earnings last quarter?

Jaguar Health, Inc. (NASDAQ:JAGX) posted its quarterly earnings results on Wednesday, November, 17th. The biotechnology company reported ($0.27) EPS for the quarter, missing the Zacks' consensus estimate of ($0.18) by $0.09. Jaguar Health had a negative trailing twelve-month return on equity of 183.74% and a negative net margin of 973.74%. During the same period in the prior year, the company posted ($0.63) earnings per share.
View Jaguar Health's earnings history
.

When did Jaguar Health's stock split? How did Jaguar Health's stock split work?

Shares of Jaguar Health reverse split on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 8th 2021. An investor that had 100 shares of Jaguar Health stock prior to the reverse split would have 33 shares after the split.

What price target have analysts set for JAGX?

1 equities research analysts have issued 1 year price targets for Jaguar Health's stock. Their forecasts range from $5.00 to $5.00. On average, they anticipate Jaguar Health's share price to reach $5.00 in the next year. This suggests a possible upside of 281.7% from the stock's current price.
View analysts' price targets for Jaguar Health
or view top-rated stocks among Wall Street analysts.

Who are Jaguar Health's key executives?

Jaguar Health's management team includes the following people:
  • Lisa A. Conte, President, Chief Executive Officer & Director
  • Carol R. Lizak, Chief Financial Officer
  • Pravin Ramsewak Chaturvedi, Chief Scientific Officer
  • Jonathan S. Wolin, Chief of Staff & Chief Compliance Officer
  • Karen J. Brunke, Executive VP-Corporate & Business Development

What other stocks do shareholders of Jaguar Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT).

When did Jaguar Health IPO?

(JAGX) raised $22 million in an IPO on Wednesday, May 13th 2015. The company issued 3,200,000 shares at $7.00 per share. Aegis Capital Corp served as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

What is Jaguar Health's stock symbol?

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

Who are Jaguar Health's major shareholders?

Jaguar Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (2.27%), BlackRock Inc. (1.68%), Principal Financial Group Inc. (0.85%), Geode Capital Management LLC (0.79%), Millennium Management LLC (0.73%) and Morgan Stanley (0.08%).
View institutional ownership trends for Jaguar Health
.

Which institutional investors are selling Jaguar Health stock?

JAGX stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Millennium Management LLC, BlackRock Inc., Principal Financial Group Inc., Geode Capital Management LLC, Citadel Advisors LLC, Truist Financial Corp, and Edmond DE Rothschild Holding S.A..
View insider buying and selling activity for Jaguar Health
or view top insider-selling stocks.

Which institutional investors are buying Jaguar Health stock?

JAGX stock was acquired by a variety of institutional investors in the last quarter, including Jump Financial LLC.
View insider buying and selling activity for Jaguar Health
or or view top insider-buying stocks.

How do I buy shares of Jaguar Health?

Shares of JAGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Jaguar Health's stock price today?

One share of JAGX stock can currently be purchased for approximately $1.31.

How much money does Jaguar Health make?

Jaguar Health has a market capitalization of $63.16 million and generates $9.39 million in revenue each year.

How many employees does Jaguar Health have?

Jaguar Health employs 34 workers across the globe.

What is Jaguar Health's official website?

The official website for Jaguar Health is www.jaguaranimalhealth.com.

Where are Jaguar Health's headquarters?

Jaguar Health is headquartered at 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105.

How can I contact Jaguar Health?

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The biotechnology company can be reached via phone at (415) 371-8300.


This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.